Back
Results - Announcements
Sales decline 30.31% to Rs 5.31 crore
Beryl Drugs standalone net profit declines 83.87% in the December 2024 quarter
08-Feb-2025, 05:35
Net profit of Beryl Drugs declined 83.87% to Rs 0.05 crore in the quarter ended December 2024 as against Rs 0.31 crore during the previous quarter ended December 2023. Sales declined 30.31% to Rs 5.31 crore in the quarter ended December 2024 as against Rs 7.62 crore during the previous quarter ended December 2023.
Net profit of Beryl Drugs declined 83.87% to Rs 0.05 crore in the quarter ended December 2024 as against Rs 0.31 crore during the previous quarter ended December 2023. Sales declined 30.31% to Rs 5.31 crore in the quarter ended December 2024 as against Rs 7.62 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 5.31 | 7.62 | -30 |
| OPM % | 10.92 | 10.37 | - |
| PBDT | 0.46 | 0.68 | -32 |
| PBT | 0.15 | 0.37 | -59 |
| NP | 0.05 | 0.31 | -84 |
Powered by Capital Market - Live News